A detailed history of Delta Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Delta Asset Management LLC holds 731 shares of LLY stock, worth $580,516. This represents 0.06% of its overall portfolio holdings.

Number of Shares
731
Previous 723 1.11%
Holding current value
$580,516
Previous $654,000 1.07%
% of portfolio
0.06%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $6,177 - $7,680
8 Added 1.11%
731 $647,000
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $15,397 - $20,599
-26 Reduced 3.47%
723 $562,000
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $2,100 - $2,476
4 Added 0.54%
749 $436,000
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $3,912 - $5,393
-9 Reduced 1.19%
745 $400,000
Q2 2023

Aug 10, 2023

BUY
$350.74 - $468.98 $22,798 - $30,483
65 Added 9.43%
754 $353,000
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $21,433 - $25,172
-69 Reduced 9.1%
689 $236,000
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $8,038 - $9,366
25 Added 3.41%
758 $277,000
Q3 2022

Nov 09, 2022

SELL
$296.48 - $337.87 $14,824 - $16,893
-50 Reduced 6.39%
733 $237,000
Q2 2022

Aug 11, 2022

SELL
$278.73 - $327.27 $1,114 - $1,309
-4 Reduced 0.51%
783 $254,000
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $938 - $1,166
4 Added 0.51%
787 $225,000
Q2 2021

Aug 02, 2021

BUY
$180.55 - $233.54 $10,833 - $14,012
60 Added 8.3%
783 $180,000
Q2 2020

Jul 23, 2020

SELL
$136.42 - $164.18 $3,410 - $4,104
-25 Reduced 3.34%
723 $119,000
Q1 2020

Apr 27, 2020

BUY
$119.05 - $147.35 $4,642 - $5,746
39 Added 5.5%
748 $104,000
Q4 2019

Jan 31, 2020

BUY
$106.92 - $132.43 $8,767 - $10,859
82 Added 13.08%
709 $93,000
Q3 2019

Oct 31, 2019

SELL
$106.79 - $116.16 $2,669 - $2,904
-25 Reduced 3.83%
627 $70,000
Q4 2018

Feb 08, 2019

SELL
$105.9 - $118.64 $7,095 - $7,948
-67 Reduced 9.32%
652 $75,000
Q2 2018

Jul 23, 2018

BUY
$75.7 - $86.88 $2,422 - $2,780
32 Added 4.66%
719 $61,000
Q1 2018

Apr 26, 2018

SELL
$74.21 - $87.6 $4,823 - $5,694
-65 Reduced 8.64%
687 $53,000
Q4 2017

Jan 23, 2018

SELL
$81.94 - $87.89 $15,568 - $16,699
-190 Reduced 20.17%
752 $63,000
Q3 2017

Oct 26, 2017

BUY
$77.07 - $85.54 $72,599 - $80,578
942
942 $81,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Delta Asset Management LLC Portfolio

Follow Delta Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Asset Management LLC with notifications on news.